




Searching News Database: RENOIR
HSMN NewsFeed - 17 Apr 2007
Neurotech Initiates two Phase II/III Clinical Trials of NT-501 for the Treatment of Retinitis Pigmentosa
Neurotech Initiates two Phase II/III Clinical Trials of NT-501 for the Treatment of Retinitis Pigmentosa